Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Non Operating Income (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Non Operating Income for 6 consecutive years, with $1.7 million as the latest value for Q4 2018.

  • Quarterly Non Operating Income rose 12923.08% to $1.7 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $948000.0 through Dec 2018, down 52.98% year-over-year, with the annual reading at -$137.2 million for FY2025, 683.18% down from the prior year.
  • Non Operating Income hit $1.7 million in Q4 2018 for Armata Pharmaceuticals, up from -$342000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $26.4 million in Q3 2014 to a low of -$12.2 million in Q1 2015.
  • Historically, Non Operating Income has averaged $3.3 million across 5 years, with a median of $1.0 million in 2016.
  • Biggest YoY gain for Non Operating Income was 12923.08% in 2018; the steepest drop was 936.36% in 2018.
  • Year by year, Non Operating Income stood at $1.9 million in 2014, then tumbled by 67.1% to $636000.0 in 2015, then soared by 184.28% to $1.8 million in 2016, then tumbled by 99.28% to $13000.0 in 2017, then soared by 12923.08% to $1.7 million in 2018.
  • Business Quant data shows Non Operating Income for ARMP at $1.7 million in Q4 2018, -$342000.0 in Q3 2018, and -$324000.0 in Q2 2018.